Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Neurocrine Biosciences to Present New Data From Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025

Summary by Helena Independent Record
Additional Data from SAVITRI™ Study Expand on Top-Line Results Announced in April 2024SAVITRI Poster Presentation Chosen as Finalist for Psych Congress Poster Awards

22 Articles

Helena Independent RecordHelena Independent Record
+20 Reposted by 20 other sources
Center

Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025

Additional Data from SAVITRI™ Study Expand on Top-Line Results Announced in April 2024SAVITRI Poster Presentation Chosen as Finalist for Psych Congress Poster Awards

·Helena, United States
Read Full Article
lifesciencesbc.califesciencesbc.ca

Johnson & Johnson To Showcase Industry-Leading Neuropsychiatry Innovations at the 2025 Psych Congress Annual Meeting - Life Sciences British Columbia

TITUSVILLE, N.J. — Johnson & Johnson will present 21 abstracts with new real-world and clinical trial data at Psych Congress.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 91% of the sources are Center
91% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

lifesciencesbc.ca broke the news in on Monday, September 15, 2025.
Sources are mostly out of (0)

Similar News Topics

Vancouver, British Columbia icon

Vancouver, British Columbia

San Diego icon

San Diego

News
For You
SearchBlindspotLocal